Nanocarriers for mRNA therapeutics
Combining the stability of polymers with transfection efficiency of lipids, we developed polymer-lipid hybrid nanoparticles, which can be stored as lyophilized powder and display long-term storage stability also in suspension. Lyophilization does not impair transfection efficiency.
Further articles
Nanomedicine and theranostics
Diverse nanoparticle formulations based on polymers, lipids, and combinations thereof, loaded with (bio)therapeutics such as antimicrobial peptides, small molecule drugs, and nucleic acids are developed to combat infectious diseases and cancer. We further develop inorganic nanoparticles (metal and semiconductor) and drug-conjugated luminescent probes with cleavable linkers for simultaneous therapy and…
Tailor-made nanoparticles
Using top-down and bottom-up synthesis, encapsulation, surface engineering, and bioconjugation approaches, we develop nanoparticles with precisely defined and controlled size, morphology, composition, and surface functionality, and tailor them for the desired biological targets and functions.